Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maine Molecular Quality Controls is a private molecular diagnostics quality-control company that designs, manufactures, and markets external quality controls for nucleic acid testing workflows. The company serves clinical laboratories and in vitro diagnostic manufacturers with products used in inherited disease testing, infectious disease detection, oncology testing, and other molecular diagnostic applications. Its product portfolio includes control panels and related materials for multiple instrument platforms from major diagnostics companies, and it also offers custom manufacturing services from a cGMP facility. Founded in 2000 by laboratory medicine and molecular biology experts, the company is focused on improving the reliability and accuracy of patient molecular test results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maine Molecular Quality Controls.